Hepatocellular carcinoma metastasis–immune microenvironment crosstalk: emerging mechanisms and immunotherapy
Wenlong Zhu, Yanjie Zhang, Runze Jiang, Li Wang, Jin Ding · 2026
Read Hepatocellular carcinoma metastasis–immune microenvironment crosstalk: emerging mechanisms and immunotherapy by Wenlong Zhu, Yanjie Zhang, Runze Jiang, Li Wang, Jin Ding (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13621559.txt.
Description
Wenlong Zhu and four colleagues review, in 2026, how the immune neighborhood of liver cancer helps the tumor spread and how treatment might break that alliance. Hepatocellular carcinoma, the commonest liver cancer, metastasizes readily, and most patients are found too late for cure. Checkpoint inhibitor drugs that revive exhausted immune cells are now first-line therapy for advanced disease, yet the suppressive microenvironment often blunts them.
The review maps the two-way traffic between cancer cells and immune cells at every step of spread, from local invasion to seeding distant organs. Suppressive cell types shield tumors, remodel tissue, and coach immune attackers into tolerance, though some immune players fight on the patient's side. The authors catalog current strategies aimed at this microenvironment, from combination immunotherapies to cell-targeted drugs, and sketch where the field should head. Their aim is raising the share of metastatic patients who actually benefit from immunotherapy.
Catalog record
| CREATOR | Wenlong Zhu, Yanjie Zhang, Runze Jiang, Li Wang, Jin Ding |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117860 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |